| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Immunic, Inc. (IMUX) has 12 insiders with recent SEC Form 4 filings, including 5 buys and 8 sells. IMUX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.72M | $20.18M | - | |
| CFO | 560.0K | $6.57M | - | |
| Other | 330.0K | $3.87M | - | |
| COO | 330.0K | $3.87M | - | |
| Other | 315.0K | $3.70M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 10, 2021 | Nash Duane | Executive Chairman | Buy | 1,000 | $9.80 | $9,800.00 | +7.1% | +1.3% | -47.4% | |
| May 12, 2021 | Nash Duane | Executive Chairman | Buy | 4,000 | $12.75 | $51,000.00 | +39.9% | -22.4% | -59.2% | |
| Mar 2, 2021 | Muehler Andreas | Chief Medical Officer | Buy | 10,006 | $15.54 | $155,493.24 | +3.5% | - | - | |
| Mar 2, 2021 | Whaley Glenn | Pfo And Pao | Buy | 1,000 | $16.48 | $16,480.00 | +100.0% | - | - | |
| Aug 10, 2020 | Whaley Glenn | Pfo And Pao | Buy | 1,000 | $18.96 | $18,960.00 | New | - | - | |
| Jul 21, 2020 | Vitt Daniel | Chief Executive Officer | Sell | 6,300 | $14.68 | $92,510.27 | -0.9% | - | - | |
| Jul 21, 2020 | Groeppel Manfred | Chief Operating Officer | Sell | 5,650 | $14.58 | $82,355.39 | -1.0% | - | - | |
| Dec 4, 2019 | Nash Duane | Director | Sale+OE | 4,400 | $6.96 | $30,624.00 | -30.5% | - | - | |
| Sep 25, 2018 | Halperin Errol R. | Director | Sell | 99,417 | $0.29 | $28,839.87 | -100% | - | - | |
| Sep 24, 2018 | Bienaime Jean Jacques68 | Director | Sell | 26,619 | $0.30 | $8,001.67 | -59.0% | - | - |